Cargando…
Future Prospects in the Diagnosis and Management of Localized Prostate Cancer
Prostate cancer (PCa) is the commonest visceral cancer in men worldwide. Introduction of serum PSA as a highly specific biomarker for prostatic diseases has led to a dramatic increase in the diagnosis of early stage PCa in last decades. Guidelines underline that benefits as well as risks and squeals...
Autores principales: | Tefekli, Ahmet, Tunc, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791692/ https://www.ncbi.nlm.nih.gov/pubmed/24163619 http://dx.doi.org/10.1155/2013/347263 |
Ejemplares similares
-
Prostate Cancer: All Aspects
por: Tefekli, Ahmet, et al.
Publicado: (2013) -
The History of Urinary Stones: In Parallel with Civilization
por: Tefekli, Ahmet, et al.
Publicado: (2013) -
Percutaneous and Transurethral Lithotripsy for Forgotten Ureteral Stents
por: Tefekli, Ahmet
Publicado: (2013) -
Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
por: Lo Greco, Maria Chiara, et al.
Publicado: (2023) -
Cell-free DNA in the management of prostate cancer: Current status and future prospective
por: He, Wei, et al.
Publicado: (2023)